In CKD patients, calcium-based phosphate binders may cause what adverse effects?

In CKD patients, calcium-based phosphate binders may cause what adverse effects?

• A. Hypercalcemia and vascular calcification
• B. Hypocalcemia
• C. Hyperphosphatemia
• D. Anemia

Answer: (A)

When calcium-based phosphate binders are used in CKD, the extra dietary calcium absorbed from the gut can push calcium levels up. This increases the calcium-phosphate product, making precipitation of calcium-phosphate crystals more likely in soft tissues, especially blood vessels. The result is vascular calcification, which stiffens arteries and raises cardiovascular risk. Hypercalcemia from these binders is the direct mechanism behind this adverse effect. Hypocalcemia would be unlikely because these binders add calcium rather than remove it. Hyperphosphatemia is the problem these binders aim to treat, not a side effect. Anemia is not a direct consequence of calcium-based binders.

When calcium-based phosphate binders are used in CKD, the extra dietary calcium absorbed from the gut can push calcium levels up. This increases the calcium-phosphate product, making precipitation of calcium-phosphate crystals more likely in soft tissues, especially blood vessels. The result is vascular calcification, which stiffens arteries and raises cardiovascular risk. Hypercalcemia from these binders is the direct mechanism behind this adverse effect.

Hypocalcemia would be unlikely because these binders add calcium rather than remove it. Hyperphosphatemia is the problem these binders aim to treat, not a side effect. Anemia is not a direct consequence of calcium-based binders.